(R)-minalrestat

(R)-minalrestat Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name (R)-minalrestat
Generic (R)-minalrestat
Type
Formula C19H11BrF2N2O4
Weight Average: 449.202
Monoisotopic: 447.987025907
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
(R)-minalrestat
(R)-minalrestat

Innovators Monograph

You find simplified version here (R)-minalrestat



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=447950
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443921
https://www.chemspider.com/Chemical-Structure.394897.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50038843
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL292963
https://zinc.docking.org/substances/ZINC000000597385
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/BFI
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA
2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one
(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide
3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione
3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE
3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione
4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE
2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE
3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE
Breast biopsy - ultrasound
Insulin C-peptide test
Bone Marrow Tests
Lymph node biopsy
Prothrombin Time Test and INR (PT/INR)
Electrolyte Panel
Slit-lamp exam
Necrobiosis lipoidica diabeticorum
24-hour urine protein
Carbon Dioxide (CO2) in Blood
Severe menopausal vulvovaginal atrophy
Predominant skin comedones
Mild to Moderate Inflammatory Reaction of the Pharynx
Post Essential Thrombocythaemia Myelofibrosis
Negative Symptom
Acetaminophen Overdose
Otitis media acute caused by Haemophilus Influenzae
Uncomplicated Urinary Tract Infection caused by susceptible bacteria
Dysentery
Sleep Disorder